The cellular immunobiology associated with fetal and neonatal alloimmune thrombocytopenia

Transfusion and Apheresis Science

Volumn 45, Issue 1, 2011, Pages 53-59

  Stuge, Tor B ^a,b   Skogen, Bjørn ^a,b   Ahlen, Maria Therese ^a,b   Husebekk, Anne ^a,b   Urbaniak, Stanislaw J ^c,d   Bessos, Hagop ^c  

^a UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^b UNIVERSITY OF TROMSØ   (Norway)

^c SCOTTISH NATIONAL BLOOD TRANSFUSION SERVICE   (United Kingdom)

^d UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Anti HPA 1a antibodies; FNAIT; Pregnancy; Thrombocytopenia

Indexed keywords

BETA3 INTEGRIN; HLA DR ANTIGEN; MATERNAL ANTIBODY;

ARTICLE; IMMUNE RESPONSE; IMMUNOBIOLOGY; LYMPHOCYTE ACTIVATION; MAJOR HISTOCOMPATIBILITY COMPLEX; NEONATAL ALLOIMMUNE THROMBOCYTOPENIA; T LYMPHOCYTE;

ANTIGENS, HUMAN PLATELET; FEMALE; FETAL DISEASES; HUMANS; IMMUNOTHERAPY; MALE; PREGNANCY; THROMBOCYTOPENIA; THROMBOCYTOPENIA, NEONATAL ALLOIMMUNE;

EID: 84860394788     PISSN: 14730502     EISSN: 18781683     Source Type: Journal    
DOI: 10.1016/j.transci.2011.06.003     Document Type: Article

References (32)

1. Kjeldsen-Kragh J., Killie M.K., Tomter G., Golebiowska E., Randen I., Hauge R., et al. A screening and intervention program aimed to reduce mortality and serious morbidity associated with severe neonatal alloimmune thrombocytopenia. Blood 2007, 110:833-839.
2. Williamson L.M., Hackett G., Rennie J., Palmer C.R., Maciver C., Hadfield R., et al. The natural history of fetomaternal alloimmunization to the platelet-specific antigen HPA-1a (PlA1, Zwa) as determined by antenatal screening. Blood 1998, 92:2280-2287.
3. Mueller-Eckhardt C., Kiefel V., Grubert A., Kroll H., Weisheit M., Schmidt S., et al. 348 cases of suspected neonatal alloimmune thrombocytopenia. Lancet 1989, 1:363-366.
4. Muller J.Y., Reznikoff-Etievant M.F., Patereau C., Dangu C., Chesnel N. Neonatal alloimmune thrombopenia. Clinical and biological study of 84 cases. Presse Med 1985, 14:83-86.
5. Spencer J.A., Burrows R.F. Feto-maternal alloimmune thrombocytopenia: a literature review and statistical analysis. Aust N Z J Obstet Gynaecol 2001, 41:45-55.
6. Skogen Br., Killie MKr, Kjeldsen-Kragh J., Ahlen M.T., Tiller H., Stuge T.B., et al. Reconsidering fetal and neonatal alloimmune thrombocytopenia with a focus on screening and prevention. Expert Rev Hematol 2010, 3:559-566.
7. Newman P.J., Derbes R.S., Aster R.H. The human platelet alloantigens, PlA1 and PlA2, are associated with a leucine33/proline33 amino acid polymorphism in membrane glycoprotein IIIa, and are distinguishable by DNA typing. J Clin Invest 1989, 83:1778-1781.
8. Valentin N., Vergracht A., Bignon J.D., Cheneau M.L., Blanchard D., Kaplan C., et al. HLA-DRw52a is involved in alloimmunization against PL-A1 antigen. Hum Immunol 1990, 27:73-79.
9. L'Abbe D., Tremblay L., Filion M., Busque L., Goldman M., Decary F., et al. Alloimmunization to platelet antigen HPA-1a (PIA1) is strongly associated with both HLA-DRB3*0101 and HLA-DQB1*0201. Hum Immunol 1992, 34:107-114.
10. Gorski J., Mach B. Polymorphism of human Ia antigens: gene conversion between two DR beta loci results in a new HLA-D/DR specificity. Nature 1986, 322:67-70.
11. Parry C.S., Gorski J., Stern L.J. Crystallographic structure of the human leukocyte antigen DRA, DRB3*0101: models of a directional alloimmune response and autoimmunity. J Mol Biol 2007, 371:435-446.
12. Wu S., Maslanka K., Gorski J. An integrin polymorphism that defines reactivity with alloantibodies generates an anchor for MHC class II peptide binding: a model for unidirectional alloimmune responses. J Immunol 1997, 158:3221-3226.
13. Maslanka K., Yassai M., Gorski J. Molecular identification of T cells that respond in a primary bulk culture to a peptide derived from a platelet glycoprotein implicated in neonatal alloimmune thrombocytopenia. J Clin Invest 1996, 98:1802-1808.
14. Sukati H., Bessos H., Barker R.N., Urbaniak S.J. Characterization of the alloreactive helper T-cell response to the platelet membrane glycoprotein IIIa (integrin-beta3) in human platelet antigen-1a alloimmunized human platelet antigen-1b1b women. Transfusion 2005, 45:1165-1177.
15. Jackson D.J., Murphy M.F., Soothill P.W., Lucas G.F., Elson C.J., Kumpel B.M. Reactivity of T cells from women with antibodies to the human platelet antigen (HPA)-1a to peptides encompassing the HPA-1 polymorphism. Clin Exp Immunol 2005, 142:92-102.
16. Ahlen M.T., Husebekk A., Killie M.K., Skogen B., Stuge T.B. T-cell responses associated with neonatal alloimmune thrombocytopenia: isolation of HPA-1a-specific, HLA-DRB3*0101-restricted CD4+ T cells. Blood 2009, 113:3838-3844.
17. Rayment R., Kooij T.W., Zhang W., Siebold C., Murphy M.F., Allen D., et al. Evidence for the specificity for platelet HPA-1a alloepitope and the presenting HLA-DR52a of diverse antigen-specific helper T cell clones from alloimmunized mothers. J Immunol 2009, 183:677-686.
18. Santoso S., Kroll H., Andrei-Selmer C.L., Socher I., Rankin A., Kretzschmar E., et al. A naturally occurring LeuVal mutation in beta3-integrin impairs the HPA-1a epitope: the third allele of HPA-1. Transfusion 2006, 46:790-799.
19. Anani Sarab G., Moss M., Barker R.N., Urbaniak S.J. Naturally processed peptides spanning the HPA-1a polymorphism are efficiently generated and displayed from platelet glycoprotein by HLA-DRB3*0101-positive antigen-presenting cells. Blood 2009, 114:1954-1957.
20. Tang T.F., Wang J., Slack R., Lin Y.S., Li L., Heine U., et al. DRB1*03 diversity and DRB3 associations in five major population groups in the United States. Hum Immunol 2002, 63:221-228.
21. Klitz W., Maiers M., Spellman S., Baxter-Lowe L.A., Schmeckpeper B., Williams T.M., et al. New HLA haplotype frequency reference standards: high-resolution and large sample typing of HLA DR-DQ haplotypes in a sample of European Americans. Tissue Antigens 2003, 62:296-307.
22. Hynes R.O. Integrins: versatility, modulation, and signaling in cell adhesion. Cell 1992, 69:11-25.
23. Killie M.K., Husebekk A., Kjeldsen-Kragh J., Skogen B. A prospective study of maternal anti-HPA 1a antibody level as a potential predictor of alloimmune thrombocytopenia in the newborn. Haematologica 2008, 93:870-877.
24. Turner M.L., Bessos H., Fagge T., Harkness M., Rentoul F., Seymour J., et al. Prospective epidemiologic study of the outcome and cost-effectiveness of antenatal screening to detect neonatal alloimmune thrombocytopenia due to anti-HPA-1a. Transfusion 2005, 45:1945-1956.
25. Kumpel B.M., Sibley K., Jackson D.J., White G., Soothill P.W. Ultrastructural localization of glycoprotein IIIa (GPIIIa, beta 3 integrin) on placental syncytiotrophoblast microvilli: implications for platelet alloimmunization during pregnancy. Transfusion 2008, 48:2077-2086.
26. Zhang L., Wang Y., Liao A.H. Quantitative abnormalities of fetal trophoblast cells in maternal circulation in preeclampsia. Prenat Diagn 2008, 28:1160-1166.
27. Huppertz B., Kingdom J., Caniggia I., Desoye G., Black S., Korr H., et al. Hypoxia favours necrotic versus apoptotic shedding of placental syncytiotrophoblast into the maternal circulation. Placenta 2003, 24:181-190.
28. Saito S. Cytokine network at the feto-maternal interface. J Reprod Immunol 2000, 47:87-103.
29. Sun J.B., Raghavan S., Sjoling A., Lundin S., Holmgren J. Oral tolerance induction with antigen conjugated to cholera toxin B subunit generates both Foxp3+CD25+ and Foxp3-CD25- CD4+ regulatory T cells. J Immunol 2006, 177:7634-7644.
30. Akdis M., Akdis C.A. Therapeutic manipulation of immune tolerance in allergic disease. Nat Rev Drug Discovery 2009, 8:645-660.
31. Larche M., Akdis C.A., Valenta R. Immunological mechanisms of allergen-specific immunotherapy. Nat Rev Immunol 2006, 6:761-771.
32. Francis J.N., Till S.J., Durham S.R. Induction of IL-10+CD4+CD25+ T cells by grass pollen immunotherapy. J Allergy Clin Immunol 2003, 111:1255-1261.